Intellia Therapeutics, Inc. short interest in 2026
In 2026, Intellia Therapeutics, Inc.'s disclosed short interest ran from 36.74% of shares outstanding on 15 Jan 2026 to 33.31% on 15 Sep 2026, a change of -3.43 percentage points. The year's high was 39.13% on 30 Jan 2026 and its low 31.16% on 30 Apr 2026, averaging 34.47% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.28 days on 27 Feb 2026. Full history: Intellia Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 36.74% (15 Jan 2026)
- End of year
- 33.31% (15 Sep 2026)
- Change
- -3.43 pp
- High
- 39.13% (30 Jan 2026)
- Low
- 31.16% (30 Apr 2026)
- Average
- 34.47%
- Highest days to cover
- 17.28 (27 Feb 2026)
- SEC filings marked
- 7
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 36.74% | 7.53 | |
| 30 Jan 2026 | 39.13% | 5.69 | |
| 13 Feb 2026 | 38.31% | 11.92 | |
| 27 Feb 2026 | 37.51% | 17.28 | 10-K filed, results (8-K) |
| 13 Mar 2026 | 33.39% | 7.66 | |
| 31 Mar 2026 | 32.97% | 10.84 | |
| 15 Apr 2026 | 32.85% | 15.42 | |
| 30 Apr 2026 | 31.16% | 4.31 | results (8-K) |
| 15 May 2026 | 37.11% | 7.68 | 10-Q filed, results (8-K) |
| 29 May 2026 | 34.72% | 9.23 | |
| 15 Jun 2026 | 36.01% | 7.46 | |
| 30 Jun 2026 | 35.23% | 7.54 | |
| 15 Jul 2026 | 32.76% | 9.75 | |
| 31 Jul 2026 | 31.41% | 11.96 | |
| 14 Aug 2026 | 32.03% | 13.15 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 31.35% | 12.89 | |
| 15 Sep 2026 | 33.31% | 14.10 |
See also: Intellia Therapeutics, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.